S. 252 — what changed
Prematurity Research Expansion and Education for Mothers who deliver Infants Early Reauthorization Act
From Referred in House to Enrolled Bill. 1 section amended, 8 added, and 3 removed between Referred in House and Enrolled Bill.
Section 1 Table of contents
changed
This The table of contents for this Act may be cited is as the “Prematurity Research Expansion and Education for Mothers who deliver Infants Early Reauthorization Act” or the “PREEMIE Reauthorization Act”.follows:
Sec. 2 Research and activities at the centers for disease control and prevention
removed
removed
“(b) Studies and Activities on Preterm Birth
removed
“(1) In general—The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, may, subject to the availability of appropriations—
removed
“(A) conduct epidemiological studies on the clinical, biological, social, environmental, genetic, and behavioral factors relating to prematurity, as appropriate;
removed
“(B) conduct activities to improve national data to facilitate tracking the burden of preterm birth; and
removed
“(C) continue efforts to prevent preterm birth, including late preterm birth, through the identification of opportunities for prevention and the assessment of the impact of such efforts.
removed
“(2) Report—Not later than 2 years after the date of enactment of the PREEMIE Reauthorization Act, and every 2 years thereafter, the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall submit to the appropriate committees of Congress reports concerning the progress and any results of studies conducted under paragraph (1).”
Sec. 3 Activities at the health resources and services administration
removed
removed
“(A) the core risk factors for preterm labor and delivery;
removed
“(B) medically indicated deliveries before full term;
removed
“(C) the importance of preconception and prenatal care, including—
removed
“(i) smoking cessation;
removed
“(ii) weight maintenance and good nutrition, including folic acid;
removed
“(iii) the screening for and the treatment of infections; and
removed
“(iv) stress management;
removed
“(D) treatments and outcomes for premature infants, including late preterm infants;
removed
“(E) the informational needs of families during the stay of an infant in a neonatal intensive care unit; and
removed
“(F) utilization of evidence-based strategies to prevent birth injuries;”
removed
“(2) programs to increase the availability, awareness, and use of pregnancy and post-term information services that provide evidence-based, clinical information through counselors, community outreach efforts, electronic or telephonic communication, or other appropriate means regarding causes associated with prematurity, birth defects, or health risks to a post-term infant;”
Sec. 4 Other activities
removedSec. 101 Short title
addedadded This title may be cited as the “Prematurity Research Expansion and Education for Mothers who deliver Infants Early Reauthorization Act” or the “PREEMIE Reauthorization Act”.
Sec. 102 Research and activities at the Centers for Disease Control and Prevention
addedadded “(b) Studies and Activities on Preterm Birth
added “(1) In general—The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, may, subject to the availability of appropriations—
added “(A) conduct epidemiological studies on the clinical, biological, social, environmental, genetic, and behavioral factors relating to prematurity, as appropriate;
added “(B) conduct activities to improve national data to facilitate tracking the burden of preterm birth; and
added “(C) continue efforts to prevent preterm birth, including late preterm birth, through the identification of opportunities for prevention and the assessment of the impact of such efforts.
added “(2) Report—Not later than 2 years after the date of enactment of the PREEMIE Reauthorization Act, and every 2 years thereafter, the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall submit to the appropriate committees of Congress reports concerning the progress and any results of studies conducted under paragraph (1).”
Sec. 103 Activities at the Health Resources and Services Administration
addedadded “(A) the core risk factors for preterm labor and delivery;
added “(B) medically indicated deliveries before full term;
added “(C) the importance of preconception and prenatal care, including—
added “(i) smoking cessation;
added “(ii) weight maintenance and good nutrition, including folic acid;
added “(iii) the screening for and the treatment of infections; and
added “(iv) stress management;
added “(D) treatments and outcomes for premature infants, including late preterm infants;
added “(E) the informational needs of families during the stay of an infant in a neonatal intensive care unit; and
added “(F) utilization of evidence-based strategies to prevent birth injuries;”
added “(2) programs to increase the availability, awareness, and use of pregnancy and post-term information services that provide evidence-based, clinical information through counselors, community outreach efforts, electronic or telephonic communication, or other appropriate means regarding causes associated with prematurity, birth defects, or health risks to a post-term infant;”
Sec. 104 Other activities
addedSec. 201 Short title
addedadded This title may be cited as the “National Pediatric Research Network Act of 2013”.
Sec. 202 National Pediatric Research Network
addedadded Section 409D of the Public Health Service Act (42 U.S.C. 284h; relating to the Pediatric Research Initiative) is amended—
added “(d) National Pediatric Research Network
added “(1) Network—In carrying out the Initiative, the Director of NIH, in consultation with the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and in collaboration with other appropriate national research institutes and national centers that carry out activities involving pediatric research, may provide for the establishment of a National Pediatric Research Network in order to more effectively support pediatric research and optimize the use of Federal resources. Such National Pediatric Research Network may be comprised of, as appropriate—
added “(A) the pediatric research consortia receiving awards under paragraph (2); or
added “(B) other consortia, centers, or networks focused on pediatric research that are recognized by the Director of NIH and established pursuant to the authorities vested in the National Institutes of Health by other sections of this Act.
added “(2) Pediatric research consortia
added “(A) In general—The Director of NIH may award funding, including through grants, contracts, or other mechanisms, to public or private nonprofit entities for providing support for pediatric research consortia, including with respect to—
added “(i) basic, clinical, behavioral, or translational research to meet unmet needs for pediatric research; and
added “(ii) training researchers in pediatric research techniques in order to address unmet pediatric research needs.
added “(B) Research—The Director of NIH shall, as appropriate, ensure that—
added “(i) each consortium receiving an award under subparagraph (A) conducts or supports at least one category of research described in subparagraph (A)(i) and collectively such consortia conduct or support such categories of research; and
added “(ii) one or more such consortia provide training described in subparagraph (A)(ii).
added “(C) Organization of consortium—Each consortium receiving an award under subparagraph (A) shall—
added “(i) be formed from a collaboration of cooperating institutions;
added “(ii) be coordinated by a lead institution or institutions;
added “(iii) agree to disseminate scientific findings, including from clinical trials, rapidly and efficiently, as appropriate, to—
added “(I) other consortia;
added “(II) the National Institutes of Health;
added “(III) the Food and Drug Administration;
added “(IV) and other relevant agencies; and
added “(iv) meet such requirements as may be prescribed by the Director of NIH.
added “(D) Supplement, not supplant—Any support received by a consortium under subparagraph (A) shall be used to supplement, and not supplant, other public or private support for activities authorized to be supported under this paragraph.
added “(E) Duration of support—Support of a consortium under subparagraph (A) may be for a period of not to exceed 5 years. Such period may be extended at the discretion of the Director of NIH.
added “(3) Coordination of consortia activities—The Director of NIH shall, as appropriate—
added “(A) provide for the coordination of activities (including the exchange of information and regular communication) among the consortia established pursuant to paragraph (2); and
added “(B) require the periodic preparation and submission to the Director of reports on the activities of each such consortium.
added “(4) Assistance with registries—Each consortium receiving an award under paragraph (2)(A) may provide assistance, as appropriate, to the Centers for Disease Control and Prevention for activities related to patient registries and other surveillance systems upon request by the Director of the Centers for Disease Control and Prevention.
added “(e) Research on pediatric rare diseases or conditions—In making awards under subsection (d)(2) for pediatric research consortia, the Director of NIH shall ensure that an appropriate number of such awards are awarded to such consortia that agree to—
added “(1) consider pediatric rare diseases or conditions, or those related to birth defects; and
added “(2) conduct or coordinate one or more multisite clinical trials of therapies for, or approaches to, the prevention, diagnosis, or treatment of one or more pediatric rare diseases or conditions.”
Sec. 301 Short title
addedadded This title may be cited as the “CHIMP Act Amendments of 2013”.
Sec. 302 Care for NIH chimpanzees
addedadded “(1) In general—Of the amount appropriated for the National Institutes of Health, there are authorized to be appropriated to carry out this section and for the care, maintenance, and transportation of all chimpanzees otherwise under the ownership or control of the National Institutes of Health, and to enable the National Institutes of Health to operate more efficiently and economically by decreasing the overall Federal cost of providing for the care, maintenance, and transportation of chimpanzees—
added “(A) for fiscal year 2014, $12,400,000;
added “(B) for fiscal year 2015, $11,650,000;
added “(C) for fiscal year 2016, $10,900,000;
added “(D) for fiscal year 2017, $10,150,000; and
added “(E) for fiscal year 2018, $9,400,000.”
added “(3) Biennial report—Not later than 180 days after the date enactment of this Act, the Director of the National Institutes of Health shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations in the House of Representatives a report, to be updated biennially, regarding—
added “(A) the care, maintenance, and transportation of the chimpanzees under the ownership or control of the National Institutes of Health;
added “(B) costs related to such care, maintenance, and transportation, and any other related costs; and
added “(C) the research status of such chimpanzees.”